Regulus Therapeutics Inc. said Pascale Witz was elected to the board at the company's June 1 annual stockholders meeting.
Most recently, she served as executive vice president, diabetes and cardiovascular, for Sanofi.
Regulus Therapeutics appoints director
Commercial Banking: June 22nd Edition
Understanding Loss Given Default A Review of Three Approaches
Commercial Banking Newsletter June Edition - 2022
Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push
Regulus Therapeutics Inc. said Pascale Witz was elected to the board at the company's June 1 annual stockholders meeting.
Most recently, she served as executive vice president, diabetes and cardiovascular, for Sanofi.